Otrivine Study
100+
Downloads
Everyone
info
About this app
Welcome to the Otrivine Study:
The Otrivine app is a proprietary platform of ObvioHealth being used to manage a trial to study and evaluate the over-time effects of Otrivine on quality-of-life factors and cold symptoms among individuals experiencing nasal congestion associated with common cold until symptoms resolve or following up to 7 days of treatment, whichever comes first.
The Otrivine app removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject.
The result? Robust data collection, increased compliance, faster time to completion, and average cost savings of ~50% vs. traditional on-site trials.
Subject Journey
A subject who is identified as eligible for this study during pre-screening will be invited to download the Otrivine App via e-mail.
Upon download, the participants create an account and are contacted by a study team member to complete the Informed Consent process. A series of screens explain the parameters of the study, including:
o Privacy Policy
o Data Gathering & Usage
o Study Tasks & Surveys
o Time Commitment
o Option to Withdraw
Subjects will connect with a member of the study team to ask questions and obtain a comprehensive understanding of the study prior to signing the informed consent form.
Intervention Period: Daily Tasks
Subjects will contribute data to the study by completing questionnaires and data uploads over a baseline period and an 8-day active trial period. Subjects can interact with the study team via secure chat as needed.
The Otrivine app is a proprietary platform of ObvioHealth being used to manage a trial to study and evaluate the over-time effects of Otrivine on quality-of-life factors and cold symptoms among individuals experiencing nasal congestion associated with common cold until symptoms resolve or following up to 7 days of treatment, whichever comes first.
The Otrivine app removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject.
The result? Robust data collection, increased compliance, faster time to completion, and average cost savings of ~50% vs. traditional on-site trials.
Subject Journey
A subject who is identified as eligible for this study during pre-screening will be invited to download the Otrivine App via e-mail.
Upon download, the participants create an account and are contacted by a study team member to complete the Informed Consent process. A series of screens explain the parameters of the study, including:
o Privacy Policy
o Data Gathering & Usage
o Study Tasks & Surveys
o Time Commitment
o Option to Withdraw
Subjects will connect with a member of the study team to ask questions and obtain a comprehensive understanding of the study prior to signing the informed consent form.
Intervention Period: Daily Tasks
Subjects will contribute data to the study by completing questionnaires and data uploads over a baseline period and an 8-day active trial period. Subjects can interact with the study team via secure chat as needed.
Updated on
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region and age. The developer provided this information and may update it over time.
This app may share these data types with third parties
Personal info
No data collected
Learn more about how developers declare collection
Data is encrypted in transit
What's new
- Bug fixes
- UI and other enhancements
- UI and other enhancements
App support
phone
Phone number
+16465990743
About the developer
Obvio Health Usa, Inc.
obv-it@obviohealth.com
545 W 25th St Fl 20
New York, NY 10001
United States
+1 202-985-1618
